Research ExplorerScientific StaffNicolaus-Martin Kröger Publications

Prof. Dr. ID: 37856

Nicolaus-Martin Kröger

Head of Clinic

graph of relations
Affiliations
501 - 550 out of 776Page size: 50

Publications

  1. 2015

  2. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation

    Koenecke, C., Göhring, G., de Wreede, L. C., van Biezen, A., Scheid, C., Volin, L., Maertens, J., Finke, J., Schaap, N., Robin, M., Passweg, J., Cornelissen, J., Beelen, D., Heuser, M., de Witte, T. & Kröger, N., 01.03.2015, In: HAEMATOLOGICA. 100, 3, p. 400-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

    Waizenegger, J. S., Ben-Batalla, I., Weinhold, N., Meissner, T., Wroblewski, M., Janning, M., Riecken, K., Binder, M., Atanackovic, D., Taipaleenmaeki, H., Schewe, D., Sawall, S., Gensch, V., Cubas-Cordova, M., Seckinger, A., Fiedler, W., Hesse, E., Kröger, N., Fehse, B., Hose, D., Klein, B., Raab, M. S., Pantel, K., Bokemeyer, C. & Loges, S., 01.03.2015, In: LEUKEMIA. 29, 3, p. 696-704 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

    Brissot, E., Labopin, M., Beckers, M. M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G. J., Craddock, C. F., Yakoub-Agha, I., Gürman, G., Russell, N. H., Aljurf, M., Potter, M. N., Nagler, A., Ottmann, O., Cornelissen, J. J., Esteve, J. & Mohty, M., 01.03.2015, In: HAEMATOLOGICA. 100, 3, p. 392-9 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. CD133 marks a stem cell population that drives human Primary Myelofibrosis

    Triviai, I., Stübig, T., Niebuhr, B., Hussein, K., Tsiftsoglou, A., Fehse, B., Stocking, C. & Kröger, N., 27.02.2015, In: HAEMATOLOGICA. 100, 6, p. 768-79

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

    Heuser, M., Meggendorfer, M., Cruz, M. M. A., Fabisch, J., Klesse, S., Köhler, L., Göhring, G., Ganster, C., Shirneshan, K., Gutermuth, A., Cerny-Reiterer, S., Krönke, J., Panagiota, V., Haferlach, C., Koenecke, C., Platzbecker, U., Thiede, C., Schroeder, T., Kobbe, G., Ehrlich, S., Stamer, K., Döhner, K., Valent, P., Schlegelberger, B., Kroeger, N., Ganser, A., Haase, D., Haferlach, T. & Thol, F., 24.02.2015, In: LEUKEMIA. 29, 9, p. 1942-45

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  7. Efficacy and outcome of allogeneic transplantation in IgD and non secretory myeloma. A report on behalf of the myeloma subcommittee of the Chronic Malignancies Working Party of the EBMT

    Morris, C., Iacobelli, S., Gahrton, G., van Biezen, A., Drake, M., Garderet, L., Potter, M., Schattenberg, A. V., Cornelissen, J. J., Hamladji, R-M., Martelli, M., Petersen, E., Rovira, M., Bandini, G., Kröger, N-M. & de Witte, T., 20.02.2015, In: BIOL BLOOD MARROW TR. 21, 6, p. 1054-8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Diagnostic value of 18F-FDG-PET/CT for monitoring myelofibrosis after allogeneic stem cell transplantation

    Derlin, T., Büsche, G. & Kröger, N., 11.02.2015, In: NUCL MED REV. 18, 1, p. 35-6 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

    Passweg, J. R., Baldomero, H., Bader, P., Bonini, C., Cesaro, S., Dreger, P., Duarte, R. F., Dufour, C., Falkenburg, J. H. F., Farge-Bancel, D., Gennery, A., Kröger, N., Lanza, F., Nagler, A., Sureda, A. & Mohty, M., 02.02.2015, In: BONE MARROW TRANSPL. 50, 4, p. 476-482

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. How we manage JAK inhibition in allogeneic transplantation for myelofibrosis

    Ballinger, T. J., Savani, B. N., Gupta, V., Kröger, N-M. & Mohty, M., 02.2015, In: EUR J HAEMATOL. 94, 2, p. 115-119

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial

    Iacobelli, S., de Wreede, L. C., Schönland, S., Björkstrand, B., Hegenbart, U., Gruber, A., Greinix, H., Volin, L., Narni, F., Carella, A. M., Beksac, M., Bosi, A., Milone, G., Corradini, P., Friberg, K., van Biezen, A., Goldschmidt, H., de Witte, T., Morris, C., Niederwieser, D., Garderet, L., Kröger, N. & Gahrton, G., 26.01.2015, In: BONE MARROW TRANSPL. 50, 4, p. 505-510

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients

    Yousef, S., Marvin, J., Steinbach, M., Langemo, A., Kovacsovics, T., Binder, M., Kröger, N., Luetkens, T. & Atanackovic, D., 01.01.2015, In: BLOOD CANCER J. 5, p. e285

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  13. Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission

    van der Torren, C. R., van Hensbergen, Y., Luther, S., Aghai, Z., Rychnavská, Z. S., Slot, M., Scherjon, S., Kröger, N., Ganser, A., Weissinger, E. M., Goulmy, E. & Hambach, L., 01.01.2015, In: PLOS ONE. 10, 3, p. e0119595

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation

    Bartels, S., Lehmann, U., Büsche, G., Schlue, J., Mozer, M., Stadler, J., Triviai, I., Alchalby, H., Kröger, N-M. & Kreipe, H., 01.2015, In: LEUKEMIA. 29, 1, p. 253-5 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  15. Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.

    Mendorf, A., Klyuchnikov, E., Langebrake, C., Rohde, H., Ayuketang, F. A., Regier, M., Christopeit, M., Zabelina, T., Bacher, A., Stübig, T., Wolschke, C., Bacher, U. & Kroger, N., 2015, In: ACTA HAEMATOL-BASEL. 134, 3, p. 146-154

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma

    Yousef, S., Kovacsovics-Bankowski, M., Salama, M. E., Bhardwaj, N., Steinbach, M., Langemo, A., Kovacsovics, T., Marvin, J., Binder, M., Panse, J., Kröger, N., Luetkens, T. & Atanackovic, D., 2015, In: HUM VACC IMMUNOTHER. 11, 7, p. 1606-11 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2014

  18. Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia

    Thol, F., Scherr, M., Kirchner, A., Shahswar, R., Battmer, K., Kade, S., Chaturvedi, A., Koenecke, C., Stadler, M., Platzbecker, U., Thiede, C., Schroeder, T., Kobbe, G., Bug, G., Ottmann, O., Hofmann, W-K., Kröger, N., Fiedler, W., Schlenk, R., Döhner, K., Döhner, H., Krauter, J., Eder, M., Ganser, A. & Heuser, M., 31.12.2014, In: HAEMATOLOGICA.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  19. Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions-A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

    Schroeder, T., Rachlis, E., Bug, G., Stelljes, M., Klein, S., Steckel, N. K., Wolf, D., Ringhoffer, M., Czibere, A., Nachtkamp, K., Dienst, A., Kondakci, M., Stadler, M., Platzbecker, U., Uharek, L., Luft, T., Fenk, R., Germing, U., Bornhäuser, M., Kröger, N., Beelen, D. W., Haas, R. & Kobbe, G., 23.12.2014, In: BIOL BLOOD MARROW TR.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years

    Auner, H. W., Szydlo, R., Hoek, J., Goldschmidt, H., Stoppa, A. M., Morgan, G. J., Moreau, P., Attal, M., Marit, G., Russell, N., Brune, M., Cook, G., Sonneveld, P., Schönland, S., Garderet, L. & Kröger, N., 10.11.2014, In: BONE MARROW TRANSPL. 50, 2, p. 209-215

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation

    Luetkens, T., Kobold, S., Cao, Y., Ristic, M., Schilling, G., Tams, S., Bartels, B. M., Templin, J., Bartels, K., Hildebrandt, Y., Yousef, S., Marx, A., Haag, F., Bokemeyer, C., Kröger, N. & Atanackovic, D., 01.11.2014, In: CANCER IMMUNOL IMMUN. 63, 11, p. 1151-62 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

    Stern, M., de Wreede, L. C., Brand, R., van Biezen, A., Dreger, P., Mohty, M., de Witte, T. M., Kröger, N. & Ruutu, T., 01.11.2014, In: LEUKEMIA. 28, 11, p. 2235-40 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis

    Robin, M., Giannotti, F., Deconinck, E., Mohty, M., Michallet, M., Sanz, G., Chevallier, P., Cahn, J-Y., Legrand, F., Rovira, M., Passweg, J., Sierra, J., Nguyen, S., Maillard, N., Yakoub-Agha, I., Linkesch, W., Cannell, P., Marcatti, M., Bay, J-O., Chalandon, Y., Kröger, N., Gluckman, E., Rocha, V., Olavarria, E., Ruggeri, A. & Eurocord and Chronic Malignancies Working Party-European Group for Blood and Marrow Transplantation (CMWP-EBMT), 01.11.2014, In: BIOL BLOOD MARROW TR. 20, 11, p. 1841-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party

    Onida, F., Brand, R., van Biezen, A., Schaap, M., von dem Borne, P. A., Maertens, J., Beelen, D. W., Carreras, E., Alessandrino, E. P., Volin, L., Kuball, J. H. E., Figuera, A., Sierra, J., Finke, J., Kröger, N., de Witte, T. & MDS subcommittee of the EBMT-CMWP, 01.10.2014, In: HAEMATOLOGICA. 99, 10, p. 1582-90 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide

    Morris, C., de Wreede, L., Scholten, M., Brand, R., van Biezen, A., Sureda, A., Dickmeiss, E., Trneny, M., Apperley, J., Chiusolo, P., van Imhoff, G. W., Lenhoff, S., Martinelli, G., Hentrich, M., Pabst, T., Onida, F., Quinn, M., Kröger, N-M., de Witte, T., Ruutu, T. & Chronic Malignancies and Lymphoma Working Parties of the EBMT, 01.10.2014, In: TRANSFUSION. 54, 10, p. 2514-22 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Allogeneic stem cell transplant vs.Janus kinase inhibition in the treatment of primary myelofibrosis or myelofibrosis after essential thrombocythemia or polycythemia vera

    Alchalby, H. & Kröger, N., 01.09.2014, In: CL LYMPH MYELOM LEUK. 14 Suppl, p. S36-41

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT

    Chalandon, Y., Passweg, J. R., Guglielmi, C., Iacobelli, S., Apperley, J., Schaap, N. P. M., Finke, J., Robin, M., Fedele, R., Bron, D., Yakoub-Agha, I., van Biezen, A., de Witte, T., Kröger, N., Olavarria, E. & Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT), 01.09.2014, In: HAEMATOLOGICA. 99, 9, p. 1492-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT

    Sarkar, S., Scherwath, A., Schirmer, L., Schulz-Kindermann, F., Neumann, K., Kruse, M., Dinkel, A., Kunze, S., Balck, F., Kröger, N., Koch, U. & Mehnert, A., 01.09.2014, In: BONE MARROW TRANSPL. 49, 9, p. 1217-22 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis

    Gupta, V., Gotlib, J., Radich, J. P., Kröger, N. M., Rondelli, D., Verstovsek, S. & Deeg, H. J., 01.09.2014, In: BIOL BLOOD MARROW TR. 20, 9, p. 1274-81 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

    Hussein, A. A., Halkes, C. M., Socié, G., Tichelli, A., von dem Borne, P. A., Schaap, M. N. P. M., Foa, R., Ganser, A., Dufour, C., Bacigalupo, A., Locasciulli, A., Aljurf, M., Peters, C., Robin, M., van Biezen, A. A., Volin, L., De Witte, T., Marsh, J., Passweg, J. R., Kröger, N-M. & Severe Aplastic Anemia and Chronic Malignancies Working Parties of the European Group for Blood and Marrow Transplantation, 01.09.2014, In: BIOL BLOOD MARROW TR. 20, 9, p. 1448-50 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy?

    de Witte, T. M., Bowen, D., Robin, M., Malcovati, L., Mufti, G., Niederwieser, D., Yakoubagha, I., Kröger, N. & Myelodysplastic Syndrome Stem Cell Transplant Guidelines Preparation Group from the Chronic Malignancies Working Party, European Group for Blood and Marrow Transplantation and European LeukemiaNet, 01.09.2014, In: CL LYMPH MYELOM LEUK. 14 Suppl, p. S42-5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)

    Barosi, G., Tefferi, A., Besses, C., Birgegard, G., Cervantes, F., Finazzi, G., Gisslinger, H., Griesshammer, M., Harrison, C., Hehlmann, R., Hermouet, S., Kiladjian, J-J., Kröger, N., Mesa, R., Mc Mullin, M. F., Pardanani, A., Passamonti, F., Samuelsson, J., Vannucchi, A. M., Reiter, A., Silver, R. T., Verstovsek, S., Tognoni, G. & Barbui, T., 25.08.2014, In: LEUKEMIA.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

    Stübig, T., Alchalby, H., Ditschkowski, M., Wolf, D., Wulf, G., Zabelina, T., Wolschke, C., Ayuketang, F. A. & Kröger, N., 01.08.2014, In: LEUKEMIA. 28, 8, p. 1736-8 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

    Mohty, M., Hübel, K., Kröger, N., Aljurf, M., Apperley, J., Basak, G. W., Bazarbachi, A., Douglas, K., Gabriel, I., Garderet, L., Geraldes, C., Jaksic, O., Kattan, M. W., Koristek, Z., Lanza, F., Lemoli, R. M., Mendeleeva, L., Mikala, G., Mikhailova, N., Nagler, A., Schouten, H. C., Selleslag, D., Suciu, S., Sureda, A., Worel, N., Wuchter, P., Chabannon, C. & Duarte, R. F., 01.07.2014, In: BONE MARROW TRANSPL. 49, 7, p. 865-72 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

    Panagiota, V., Thol, F., Markus, B., Fehse, B., Alchalby, H., Badbaran, A., Lehmann, U., Koenecke, C., Shahswar, R., Chaturvedi, A., Stadler, M., Eder, M., Göhring, G., Koenigsmann, M., Kloos, A., Trummer, A., Schroeder, T., Kobbe, G., Thiede, C., Platzbecker, U., Schlegelberger, B., Kreipe, H-H., Ganser, A., Kröger, N. & Heuser, M., 01.07.2014, In: LEUKEMIA. 28, 7, p. 1552-5 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Relapse assessment following allogeneic SCT in patients with MDS and AML

    Christopeit, M., Kröger, N., Haferlach, T. & Bacher, U., 01.07.2014, In: ANN HEMATOL. 93, 7, p. 1097-110 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis

    Triviai, I., Ziegler, M., Bergholz, U., Oler, A. J., Stübig, T., Prassolov, V., Fehse, B., Kozak, C. A., Kröger, N-M. & Stocking, C., 10.06.2014, In: P NATL ACAD SCI USA. 111, 23, p. 8595 - 8600

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis

    Kröger, N., Zabelina, T., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., von Huenerbein, N., Kvasnicka, H-M., Thiele, J., Kreipe, H-H. & Büsche, G., 01.06.2014, In: BIOL BLOOD MARROW TR. 20, 6, p. 812-5 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

    Passweg, J. R., Baldomero, H., Peters, C., Gaspar, H. B., Cesaro, S., Dreger, P., Duarte, R. F., Falkenburg, J. H. F., Farge-Bancel, D., Gennery, A., Halter, J., Kröger, N., Lanza, F., Marsh, J., Mohty, M., Sureda, A., Velardi, A., Madrigal, A. & European Society for Blood and Marrow Transplantation (EBMT), 01.06.2014, In: BONE MARROW TRANSPL. 49, 6, p. 744-50 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Low frequency of calreticulin mutations in MDS patients

    Heuser, M., Panagiota, V., Koenecke, C., Fehse, B., Alchalby, H., Badbaran, A., Shahswar, R., Stadler, M., Eder, M., Göhring, G., Trummer, A., Schroeder, T., Kobbe, G., Thiede, C., Platzbecker, U., Schlegelberger, B., Kroeger, N., Ganser, A. & Thol, F., 21.05.2014, In: LEUKEMIA.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation

    Chemaly, R. F., Ullmann, A. J., Stoelben, S., Richard, M. P., Bornhäuser, M., Groth, C., Einsele, H., Silverman, M., Mullane, K. M., Brown, J., Nowak, H., Kölling, K., Stobernack, H. P., Lischka, P., Zimmermann, H., Rübsamen-Schaeff, H., Champlin, R. E., Ehninger, G. & AIC246 Study Team, 08.05.2014, In: NEW ENGL J MED. 370, 19, p. 1781-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

    Lussana, F., Rambaldi, A., Finazzi, M. C., van Biezen, A., Scholten, M., Oldani, E., Carobbio, A., Iacobelli, S., Finke, J., Nagler, A., Volin, L., Lamy, T., Arnold, R., Mohty, M., Michallet, M., de Witte, T., Olavarria, E. & Kröger, N., 01.05.2014, In: HAEMATOLOGICA. 99, 5, p. 916-21 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma

    Atanackovic, D., Luetkens, T. & Kröger, N., 01.05.2014, In: LEUKEMIA. 28, 5, p. 993-1000 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation

    Ayuketang, F. A., Bussmann, L., Zabelina, T., Veit, R., Alchalby, H., Wolschke, C., Lellek, H., Bacher, U., Zander, A. R. & Kröger, N., 01.05.2014, In: ANN HEMATOL. 93, 5, p. 855-61 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines

    Nitsch, E., Mina, S., Brammer, I., Pace, A., Schuch, G., Bokemeyer, C., Zander, A., Kröger, N-M. & Ayuketang, F. A., 01.04.2014, In: ANTICANCER RES. 34, 4, p. 1779-84 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. 5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity

    Stübig, T., Badbaran, A., Luetkens, T., Hildebrandt, Y., Atanackovic, D., Binder, T. M. C., Fehse, B. & Kröger, N-M., 13.03.2014, In: MEDIAT INFLAMM. 2014, p. 418292

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies

    Klyuchnikov, E., El-Cheikh, J., Sputtek, A., Lioznov, M., Calmels, B., Furst, S., Chabannon, C., Crocchiolo, R., Lemarié, C., Faucher, C., Bacher, U., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., Reckhaus, M-L., Blaise, D. & Kröger, N-M., 01.03.2014, In: BIOL BLOOD MARROW TR. 20, 3, p. 382-6 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell Transplantation: results of different dosage levels in clinical practice

    Langebrake, C., Rohde, H., Lellek, H., Wolschke, C. & Kröger, N-M., 01.03.2014, In: CLIN TRANSPLANT. 28, 3, p. 286-91 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

    Fu, Y., Schroeder, T., Zabelina, T., Badbaran, A., Bacher, U., Kobbe, G., Ayuketang, F. A., Wolschke, C., Schnittger, S., Kohlmann, A., Haferlach, T. & Kröger, N., 01.03.2014, In: EUR J HAEMATOL. 92, 3, p. 189-94 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation

    Alchalby, H., Zabelina, T., Stübig, T., van Biezen, A., Bornhäuser, M., Di Bartolomeo, P., Beelen, D., Cahn, J. Y., Dreger, P., Schroyens, W., de Witte, T., Olavarria, E., Kröger, N. & Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT), 01.02.2014, In: BIOL BLOOD MARROW TR. 20, 2, p. 279-81 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Immune-modulating drugs and hypomethylating agents to prevent or treat relapse after allogeneic stem cell transplantation

    Kröger, N., Stübig, T. & Atanackovic, D., 01.02.2014, In: BIOL BLOOD MARROW TR. 20, 2, p. 168-72 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study

    de Wreede, L. C., Watson, M., van Os, M., Milligan, D., van Gelder, M., Michallet, M., Dreger, P., Dearden, C. E., Homewood, J., Dupuis, J., Leporrier, M., Karas, M., Corront, B., Baerlocher, G. M., Herr, W., Choquet, S., Niederwieser, D. W., Sutton, L., Kröger, N., de Witte, T. M. & Schetelig On Behalf Of The Chronic Malignancies Working Party Of The Ebmt And The Uk Medical Research Council, J., 01.02.2014, In: AM J HEMATOL. 89, 2, p. 174-80 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...7 8 9 10 11 12 13 14 ...16 Next